Summary:
The purpose of this study is to provide efficacy and safety data in COPD
patients with moderate to severe airflow limitation in a 12-week treatment.
Qualified Participants Must:
• Be over 40 years of age
•
Have stable COPD
•
Have airflow limitation indicated by a post-bronchodilator
•
Be a current or ex-smoker who has a smoking history of at least 10 pack years
Qualified Participants May Receive:
Study medication, study related medical care and may be compensated for time and travel